-
1
-
-
33748921339
-
-
Siegrist CA, Aebi C, Desgrandchamps D, Heininger U, Vaudaux B. Guide sur les vaccinations: Evidences et croyances... Bulletin des médecins suisses 2005;86:9.(http://www.saez.ch/pdf/2005/2005-09/2005-09-152.PDF).
-
(2005)
Guide Sur Les Vaccinations: Evidences et Croyances... Bulletin des Médecins Suisses
, vol.86
, pp. 9
-
-
Siegrist, C.A.1
Aebi, C.2
Desgrandchamps, D.3
Heininger, U.4
Vaudaux, B.5
-
2
-
-
33748938994
-
Les enfants des médecins sont mieux vaccinés que les autres enfants
-
Siegrist CA, Aebi C, Desgrandchamps D, et al. Les enfants des médecins sont mieux vaccinés que les autres enfants. Bulletin OFSP 2005;37:642-5.
-
(2005)
Bulletin OFSP
, vol.37
, pp. 642-645
-
-
Siegrist, C.A.1
Aebi, C.2
Desgrandchamps, D.3
-
3
-
-
33645055162
-
How do physicians immunize their own children? Differences among pediatricians and non pediatricians
-
Posfay-Barbe K, Heininger U, Aebi C, et al. How Do Physicians Immunize Their Own Children? Differences Among Pediatricians and Non pediatricians. Pediatrics 2005;116:e623-33.
-
(2005)
Pediatrics
, vol.116
-
-
Posfay-Barbe, K.1
Heininger, U.2
Aebi, C.3
-
5
-
-
33748943593
-
Supplément XVII: Classeur «Maladies infectieuses - Diagnostic et prévention», Vaccination contre les pneumocoques chez les enfants de moins de 5 ans
-
Supplément XVII: Classeur «Maladies infectieuses - Diagnostic et prévention», Vaccination contre les pneumocoques chez les enfants de moins de 5 ans, Bulletin OFSP 2005;45.
-
(2005)
Bulletin OFSP
, pp. 45
-
-
-
7
-
-
0034063425
-
Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children
-
Northern California Kaiser Permanente Vaccine Study Center Group
-
Black S, Shinefield H, Fireman B, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J 2000;19:187-95.
-
(2000)
Pediatr Infect Dis J
, vol.19
, pp. 187-195
-
-
Black, S.1
Shinefield, H.2
Fireman, B.3
-
8
-
-
84921705432
-
Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and pneumonia with consolidation on x-ray in children under two years of age
-
CD004977
-
Lucero MG, Dulalia VE, Parreno RN, et al. Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and pneumonia with consolidation on x-ray in children under two years of age. Cochrane Database Syst Rev 2004;CD004977.
-
(2004)
Cochrane Database Syst Rev
-
-
Lucero, M.G.1
Dulalia, V.E.2
Parreno, R.N.3
-
9
-
-
0035825720
-
Efficacy of a pneumococcal conjugate vaccine against acute otitis media
-
Eskola J, Kilpi T, Palmu A, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 2001;344:403-9.
-
(2001)
N Engl J Med
, vol.344
, pp. 403-409
-
-
Eskola, J.1
Kilpi, T.2
Palmu, A.3
-
10
-
-
3242889984
-
Epidemiology of meningococcal disease in Switzerland, 1999-2002
-
Jaccard Ruedin H, Ninet B, Pagano E, Rohner P. Epidemiology of meningococcal disease in Switzerland, 1999-2002. Eur J Clin Microbiol Infect Dis 2004;23:517-22.
-
(2004)
Eur J Clin Microbiol Infect Dis
, vol.23
, pp. 517-522
-
-
Jaccard Ruedin, H.1
Ninet, B.2
Pagano, E.3
Rohner, P.4
-
11
-
-
33748934157
-
Supplément XVIII: Classeur «Maladies infectieuses - Diagnostic et prévention», Vaccination contre les méningocoques du sérogroupe C
-
Supplément XVIII: Classeur «Maladies infectieuses - Diagnostic et prévention», Vaccination contre les méningocoques du sérogroupe C. Bulletin OFSP 2005; 45.
-
(2005)
Bulletin OFSP
, vol.45
-
-
-
12
-
-
0036739777
-
Impact of meningococcal C conjugate vaccine in the UK
-
Balmer P, Borrow R, Miller E. Impact of meningococcal C conjugate vaccine in the UK. J Med Microbiol 2002;51:7l7-22.
-
(2002)
J Med Microbiol
, vol.51
-
-
Balmer, P.1
Borrow, R.2
Miller, E.3
-
13
-
-
3242768475
-
Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction
-
Trotter CL, Andrews NJ, Kaczmarski EB, Miller E, Ramsay ME. Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction. Lancet 2004;364:365-7.
-
(2004)
Lancet
, vol.364
, pp. 365-367
-
-
Trotter, C.L.1
Andrews, N.J.2
Kaczmarski, E.B.3
Miller, E.4
Ramsay, M.E.5
|